AAAAAA

   
Results: 1-9 |
Results: 9
ELEVATED CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER
Authors: FEUER JA LUSH RM VENZON D DURAY P TOMPKINS A SARTOR O FIGG WD
Citation: Ja. Feuer et al., ELEVATED CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER, Journal of investigative medicine, 46(2), 1998, pp. 66-72
PHASE-I TRIAL OF CONTINUOUS-INFUSION FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, IN PATIENTS WITH REFRACTORY NEOPLASMS
Authors: SENDEROWICZ AM HEADLEE D STINSON SF LUSH RM KALIL N VILLALBA L HILL K STEINBERG SM FIGG WD TOMPKINS A ARBUCK SG SAUSVILLE EA
Citation: Am. Senderowicz et al., PHASE-I TRIAL OF CONTINUOUS-INFUSION FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, IN PATIENTS WITH REFRACTORY NEOPLASMS, Journal of clinical oncology, 16(9), 1998, pp. 2986-2999
A PHASE-II STUDY OF 5-AZA-2'DEOXYCYTIDINE (DECITABINE) IN HORMONE-INDEPENDENT METASTATIC (D2) PROSTATE-CANCER
Authors: THIBAULT A FIGG WD BERGAN RC LUSH RM MYERS CE TOMPKINS A REED E SAMID D
Citation: A. Thibault et al., A PHASE-II STUDY OF 5-AZA-2'DEOXYCYTIDINE (DECITABINE) IN HORMONE-INDEPENDENT METASTATIC (D2) PROSTATE-CANCER, Tumori, 84(1), 1998, pp. 87-89
PHASE-II TRIAL OF SURAMIN, LEUPROLIDE, AND FLUTAMIDE IN PREVIOUSLY UNTREATED METASTATIC PROSTATE-CANCER
Authors: DAWSON NA FIGG WD COOPER MR SARTOR O BERGAN RC SENDEROWICZ AM STEINBERG SM TOMPKINS A WEINBERGER B SAUSVILLE EA REED E MYERS CE
Citation: Na. Dawson et al., PHASE-II TRIAL OF SURAMIN, LEUPROLIDE, AND FLUTAMIDE IN PREVIOUSLY UNTREATED METASTATIC PROSTATE-CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1470-1477
SIMILAR CLINICAL OUTCOMES IN AFRICAN-AMERICAN AND NON-AFRICAN-AMERICAN MALES TREATED WITH SURAMIN FOR METASTATIC PROSTATE-CANCER
Authors: BERGAN RC WALLS RG FIGG WD DAWSON NA HEADLEE D TOMPKINS A STEINBERG SM REED E
Citation: Rc. Bergan et al., SIMILAR CLINICAL OUTCOMES IN AFRICAN-AMERICAN AND NON-AFRICAN-AMERICAN MALES TREATED WITH SURAMIN FOR METASTATIC PROSTATE-CANCER, Journal of the National Medical Association, 89(9), 1997, pp. 622-628
FLUTAMIDE WITHDRAWAL AND CONCOMITANT INITIATION OF AMINOGLUTETHIMIDE IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER
Authors: FIGG WD DAWSON N MIDDLEMAN MN BRAWLEY O LUSH RM SENDEROWICZ A STEINBERG SH TOMPKINS A REED E SARTOR O
Citation: Wd. Figg et al., FLUTAMIDE WITHDRAWAL AND CONCOMITANT INITIATION OF AMINOGLUTETHIMIDE IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER, Acta oncologica, 35(6), 1996, pp. 763-765
DISPOSITION OF PHENYLBUTYRATE AND ITS METABOLITES, PHENYLACETATE AND PHENYLACETYLGLUTAMINE
Authors: PISCITELLI SC THIBAULT A FIGG WD TOMPKINS A HEADLEE D LIEBERMANN R SAMID D MYERS CE
Citation: Sc. Piscitelli et al., DISPOSITION OF PHENYLBUTYRATE AND ITS METABOLITES, PHENYLACETATE AND PHENYLACETYLGLUTAMINE, Journal of clinical pharmacology, 35(4), 1995, pp. 368-373
SURPRISING ACTIVITY OF FLUTAMIDE WITHDRAWAL, WHEN COMBINED WITH AMINOGLUTETHIMIDE, IN TREATMENT OF HORMONE-REFRACTORY PROSTATE-CANCER
Authors: SARTOR O COOPER M WEINBERGER M HEADLEE D THIBAULT A TOMPKINS A STEINBERG S FIGG WD LINEHAN WM MYERS CE
Citation: O. Sartor et al., SURPRISING ACTIVITY OF FLUTAMIDE WITHDRAWAL, WHEN COMBINED WITH AMINOGLUTETHIMIDE, IN TREATMENT OF HORMONE-REFRACTORY PROSTATE-CANCER, Journal of the National Cancer Institute, 86(3), 1994, pp. 222-227
CHIMERIC FUSION PROTEIN TOXIN DAB(486) IL-2 IN ADVANCED MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME - CORRELATION OF ACTIVITY AND INTERLEUKIN-2 RECEPTOR EXPRESSION IN A PHASE-II STUDY
Authors: FOSS FM BORKOWSKI TA GILLIOM M STETLERSTEVENSON M JAFFE ES FIGG WD TOMPKINS A BASTIAN A NYLEN P WOODWORTH T UDEY MC SAUSVILLE EA
Citation: Fm. Foss et al., CHIMERIC FUSION PROTEIN TOXIN DAB(486) IL-2 IN ADVANCED MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME - CORRELATION OF ACTIVITY AND INTERLEUKIN-2 RECEPTOR EXPRESSION IN A PHASE-II STUDY, Blood, 84(6), 1994, pp. 1765-1774
Risultati: 1-9 |